Gina Kolata

The new pills can lower cholesterol levels far below what can be achieved with statins, clinical trials have shown.

The condition that killed Senator Lindsey Graham is deadly, sudden and difficult to treat — “like a knife to the back,” one expert said.

Artificial intelligence programs can spot patterns in electrocardiograms that humans miss. Now, one program is going to be widely available — for free — to doctors.

Her decades of work on Huntington’s disease helped lead to the creation of a genetic test for the devastating condition. Why didn’t she take it herself?

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.

Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these patients.

A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said.

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.

The new strategy also holds promise for lung and colon tumors. Here’s how scientists discovered it.

Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.

Before the rise of GLP-1s, obesity experts didn’t study the internal buzz that compels people to eat. Now that food noise is being switched off, they want to understand it.

The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent.

In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology.